|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-02
|
$407,748
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-22
|
$136,153
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas
|
5K08CA194162-03
|
$168,264
|
SCHNEPP, ROBERT
|
EMORY UNIVERSITY
|
|
The role of JMJD6 in MYC-mediated neuroblastoma
|
1R03CA212802-01A1
|
$89,750
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
5R01CA166749-06
|
$315,213
|
ZAGE, PETER
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
5R01CA116548-12
|
$249,637
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-10
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
|
2R01CA148688-06A1
|
$413,844
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-04
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-09
|
$374,324
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Targeting nutrient-sensing pathways in cancer
|
5K22CA201103-02
|
$191,360
|
LAZARUS, MICHAEL
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Targeting Neuroblastoma with armed T cells
|
5R01CA182526-04
|
$765,563
|
LUM, LAWRENCE
|
UNIVERSITY OF VIRGINIA
|
|
Structural Variation in Neuroblastoma
|
5R01CA204974-02
|
$384,300
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Stanford Cancer Institute
|
5P30CA124435-10
|
$3,338,488
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S1
|
$116,250
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S2
|
$106,499
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S3
|
$83,463
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S4
|
$60,000
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S5
|
$180,000
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-31S6
|
$116,655
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-31
|
$3,795,641
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma
|
5R21CA187548-02
|
$163,669
|
BARANOWSKA-KORTYLEWICZ, JANINA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$512,529
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$525,343
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
|
1R01CA215753-01A1
|
$391,698
|
FABBRI, MULLER
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Role of m6A mRNA methylation in Neuroblastoma
|
1R21CA219352-01
|
$246,472
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
5R01CA180692-03
|
$606,838
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
N/A
|
National Institutes of Health
|
|
Regulation of MDM2 auto-ubiquitination and molecular targeting
|
5R01CA123490-10
|
$251,191
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$665,693
|
Thiele, Carol
|
CCR (NCI)
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-10
|
$239,246
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Pediatric Preclinical Testing Consortium
|
5U01CA199287-03
|
$357,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,583,320
|
Glod, John
|
CCR (NCI)
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$358,450
|
Thiele, Carol
|
CCR (NCI)
|
|
Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma
|
5R00CA178189-05
|
$249,000
|
ZHU, SHIZHEN
|
MAYO CLINIC ROCHESTER
|
|
Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma
|
5R01CA172067-06
|
$363,425
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
|
5R01CA197964-03
|
$348,597
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
MYC--Transcription and Apoptosis
|
5R01CA051497-26
|
$27,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Myc - Transcription and Apoptosis
|
7R01CA051497-27
|
$350,375
|
DANG, CHI
|
WISTAR INSTITUTE
|
|
Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma
|
5R01CA197903-02
|
$378,357
|
ZHONG, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
|
1U01CA217864-01
|
$1,065,613
|
WEISS, WILLIAM
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$511,155
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis
|
5K99CA197484-02
|
$160,773
|
HUANG, MILLER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$170,385
|
Khan, Javed
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|